NCT00514982 Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome Status WITHDRAWN Phase PHASE2
NCT00512278 Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C Status COMPLETED Phase PHASE2
NCT00505947 Treatment of Refractory Diabetic Macular Edema With Infliximab Status TERMINATED Phase PHASE3
NCT00463580 A Study of Infliximab for Treatment Resistant Major Depression Status COMPLETED Phase PHASE4
NCT00443222 Treatment With TNF Blockade, Infliximab, in Patients With Myositis Status COMPLETED Phase PHASE2/PHASE3
NCT00439283 Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT00432406 Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis Status COMPLETED Phase PHASE4
NCT00368264 TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL ) Status TERMINATED Phase PHASE2/PHASE3
NCT00358670 Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563) Status TERMINATED Phase PHASE3
NCT00336492 A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00325078 Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease Status TERMINATED Phase PHASE1/PHASE2
NCT00307593 RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides Status COMPLETED Phase NA
NCT00254982 Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00252369 Treatment of Perianal Crohn's Disease, Combining Medical and Surgical Treatment. Status TERMINATED Phase NA
NCT00251641 The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00246064 The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol Status COMPLETED Phase PHASE4
NCT00244179 New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis Status UNKNOWN Phase PHASE2